MEDICINA
Departamento
St James's University Hospital
Leeds, Reino UnidoPublicaciones en colaboración con investigadores/as de St James's University Hospital (2)
2020
-
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: The ASPEN study
Blood, Vol. 136, Núm. 18, pp. 2038-2050
2016
-
Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
Drugs, Vol. 76, Núm. 8, pp. 853-867